A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care
Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy drug delays cancer recurring or worsening in global trial )
Also on site :
- Third day of protests sees scattered violence, arrests, and firm resolve from federal authorities
- Stocks Rise on Hopes for China-US Talks; Dollar Weakens
- Colombian Presidential hopeful shot at Bogotá rally , Colombian president vows to hunt ‘mastermind’ behind the shooting